Mark L. Berch

Array ( [id] => 3526706 [patent_doc_number] => 05527905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Anti-tumor platinum complexes, their preparation and their therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/341702 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23015 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527905.pdf [firstpage_image] =>[orig_patent_app_number] => 341702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661891 [patent_doc_number] => 05624920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents' [patent_app_type] => 1 [patent_app_number] => 8/342197 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8483 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 684 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624920.pdf [firstpage_image] =>[orig_patent_app_number] => 342197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589862 [patent_doc_number] => 05585373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => '3-(7\'-oxo-1\'-aza-4\'-oxabicyclo[3.2.0]-hept-3\'-YL)propionic acid derivative as antitumor agent' [patent_app_type] => 1 [patent_app_number] => 8/341177 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33408 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 562 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585373.pdf [firstpage_image] =>[orig_patent_app_number] => 341177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785181 [patent_doc_number] => 05821364 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Diamine salts of clavulanic acid' [patent_app_type] => 1 [patent_app_number] => 8/338585 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3442 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821364.pdf [firstpage_image] =>[orig_patent_app_number] => 338585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3816841 [patent_doc_number] => 05770591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Bis-platinum complexes as chemotherapeutic agents' [patent_app_type] => 1 [patent_app_number] => 8/339291 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5296 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770591.pdf [firstpage_image] =>[orig_patent_app_number] => 339291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983925 [patent_doc_number] => 05861405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'S-substituted 1,3,7-trialkyl-xanthine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/335108 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22811 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861405.pdf [firstpage_image] =>[orig_patent_app_number] => 335108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733701 [patent_doc_number] => 05693801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GaBa brain receptor ligands' [patent_app_type] => 1 [patent_app_number] => 8/331561 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 11493 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693801.pdf [firstpage_image] =>[orig_patent_app_number] => 331561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634666 [patent_doc_number] => 05631260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Xanthine epoxides as A.sub.1 adenosine receptor agonists and antagonists' [patent_app_type] => 1 [patent_app_number] => 8/330640 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 8843 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631260.pdf [firstpage_image] =>[orig_patent_app_number] => 330640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3540506 [patent_doc_number] => 05495013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Process for the preparation of Diltiazem' [patent_app_type] => 1 [patent_app_number] => 8/326312 [patent_app_country] => US [patent_app_date] => 1994-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1514 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/495/05495013.pdf [firstpage_image] =>[orig_patent_app_number] => 326312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771202 [patent_doc_number] => 05849780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => '1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present' [patent_app_type] => 1 [patent_app_number] => 8/323921 [patent_app_country] => US [patent_app_date] => 1994-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35320 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849780.pdf [firstpage_image] =>[orig_patent_app_number] => 323921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686689 [patent_doc_number] => 05663159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Prodrugs of phosphonates' [patent_app_type] => 1 [patent_app_number] => 8/320632 [patent_app_country] => US [patent_app_date] => 1994-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17145 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663159.pdf [firstpage_image] =>[orig_patent_app_number] => 320632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621403 [patent_doc_number] => 05641763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activity' [patent_app_type] => 1 [patent_app_number] => 8/320591 [patent_app_country] => US [patent_app_date] => 1994-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4803 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641763.pdf [firstpage_image] =>[orig_patent_app_number] => 320591 [rel_patent_id] =>[rel_patent_doc_number] =>)